Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol vs Morphine PR in Cancer Pain
NCT01964378Phase 3Terminated
- Sponsor
- Tris Pharma
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of cebranopadol in cancer pain, sponsored by Tris Pharma. Started Oct 2013; status: terminated.
02
Drugs
cebranopadol
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01964378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964378.